Biodegradation and biocompatibility of haloarchaea-produced poly(3-hydroxybutyrate-co-3-hydroxyvalerate) copolymers

Biomaterials - Tập 139 - Trang 172-186 - 2017
Jing Han1, Lin-Ping Wu2, Xiao-Bin Liu1,3, Jing Hou4, Li-Li Zhao1,5, Jun-Yu Chen1,6, Da-He Zhao1,6, Hua Xiang1,6
1State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, People’s Republic of China
2Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, People's Republic of China
3BiolsCAS-Tianyue Genomics Joint Centre of Precision Medicine, Institutes of Life Science, Chinese Academy of Sciences, Beijing, 100101, People's Republic of China
4School of Food and Biological Engineering, Jiangsu University, Zhenjiang 212013, People's Republic of China
5Key Laboratory of Microbial Diversity Research and Application of Hebei Province, College of Life Sciences, Hebei University, Baoding, 071002, People's Republic of China
6College of Life Science, University of Chinese Academy of Sciences, Beijing, 100049, People's Republic of China

Tài liệu tham khảo

Pina, 2015, Natural-based nanocomposites for bone tissue engineering and regenerative medicine: a review, Adv. Mater., 27, 1143, 10.1002/adma.201403354 Moghimi, 2005, Nanomedicine: current status and future prospects, FASEB J., 19, 311, 10.1096/fj.04-2747rev Washington, 2017, The impact of monomer sequence and stereochemistry on the swelling and erosion of biodegradable poly(lactic-co-glycolic acid) matrices, Biomaterials, 117, 66, 10.1016/j.biomaterials.2016.11.037 Rezwan, 2006, Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering, Biomaterials, 27, 3413, 10.1016/j.biomaterials.2006.01.039 Wan, 2016, Design of PLGA-based depot delivery systems for biopharmaceuticals prepared by spray drying, Int. J. Pharm., 498, 82, 10.1016/j.ijpharm.2015.12.025 Kearney, 2013, Macroscale delivery systems for molecular and cellular payloads, Nat. Mater., 12, 1004, 10.1038/nmat3758 von Burkersroda, 2002, Why degradable polymers undergo surface erosion or bulk erosion, Biomaterials, 23, 4221, 10.1016/S0142-9612(02)00170-9 Li, 2015, Water soluble polyhydroxyalkanoates: future materials for therapeutic applications, Chem. Soc. Rev., 44, 2865, 10.1039/C5CS00089K Wu, 2016, PHB-based gels as delivery agents of chemotherapeutics for the effective shrinkage of tumors, Adv. Healthc. Mater., 5, 2679, 10.1002/adhm.201600723 Zinn, 2001, Occurrence, synthesis and medical application of bacterial polyhydroxyalkanoate, Adv. Drug Deliv. Rev., 53, 5, 10.1016/S0169-409X(01)00218-6 Jendrossek, 2014, New insights in the formation of polyhydroxyalkanoate granules (carbonosomes) and novel functions of poly(3-hydroxybutyrate), Environ. Microbiol., 16, 2357, 10.1111/1462-2920.12356 Li, 2016, Polyhydroxyalkanoates: opening doors for a sustainable future, NPG Asia Mater., 8, e265, 10.1038/am.2016.48 Gassner, 1996, Some properties of poly(3-hydroxybutyrate)-poly(3-hydroxyvalerate) blends, Polym. Int., 39, 215, 10.1002/(SICI)1097-0126(199603)39:3<215::AID-PI497>3.0.CO;2-0 Srirangan, 2016, Engineering of Escherichia coli for direct and modulated biosynthesis of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) copolymer using unrelated carbon sources, Sci. Rep., 6, 10.1038/srep36470 Sankhla, 2010, Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) co-polymer production from a local isolate, Brevibacillus invocatus MTCC 9039, Bioresour. Technol., 101, 1947, 10.1016/j.biortech.2009.10.006 Köse, 2003, Macroporous poly(3-hydroxybutyrate-co-3-hydroxyvalerate) matrices for bone tissue engineering, Biomaterials, 24, 1949, 10.1016/S0142-9612(02)00613-0 Ahmed, 2010, Polyhydroxybutyrate and its copolymer with polyhydroxyvalerate as biomaterials: influence on progression of stem cell cycle, Biomacromolecules, 11, 2707, 10.1021/bm1007579 Napathorn, 2014, Biocompatibilities and biodegradation of poly(3-hydroxybutyrate-co-3-hydroxyvalerate)s produced by a model metabolic reaction-based system, BMC Microbiol., 14, 285, 10.1186/s12866-014-0285-4 Taylor, 1994, Six bioabsorbable polymers: in vitro acute toxicity of accumulated degradation products, J. Appl. Biomater., 5, 151, 10.1002/jab.770050208 Gogolewski, 1993, Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA), J. Biomed. Mater. Res., 27, 1135, 10.1002/jbm.820270904 Liu, 2010, Influence of hydroxyvalerate composition of polyhydroxy butyrate valerate (PHBV) copolymer on bone cell viability and in vitro degradation, J. Appl. Polym. Sci., 116, 3225 Knowles, 1992, In vitro degradation a polyhydroxybutyrate/polyhydroxyvalerate copolymer, J. Mater. Sci. Mater. Med., 3, 352, 10.1007/BF00705367 Zhu, 2009, In vitro characterization of hepatocyte growth factor release from PHBV/PLGA microsphere scaffold, J. Biomed. Mater. Res. A, 89, 411, 10.1002/jbm.a.31978 Idaszek, 2013, Tailored degradation of biocompatible poly(3-hydroxybutyrate-co-3-hydroxyvalerate)/calcium silicate/poly(lactide-co-glycolide) ternary composites: an in vitro study, Mater. Sci. Eng. C Mater. Biol. Appl., 33, 4352, 10.1016/j.msec.2013.06.025 Liu, 2016, Environmental biodegradation of haloarchaea-produced poly(3-hydroxybutyrate-co-3-hydroxyvalerate) in activated sludge, Appl. Microbiol. Biotechnol., 100, 6893, 10.1007/s00253-016-7528-2 Mahansaria, 2015, Polymerase chain reaction-based screening method applicable universally to environmental haloarchaea and halobacteria for identifying polyhydroxyalkanoate producers among them, Extremophiles, 19, 1041, 10.1007/s00792-015-0775-9 Han, 2010, Wide distribution among halophilic archaea of a aovel polyhydroxyalkanoate synthase subtype with homology to bacterial type III synthases, Appl. Environ. Microbiol., 76, 7811, 10.1128/AEM.01117-10 Yin, 2015, Halophiles, coming stars for industrial biotechnology, Biotechnol. Adv., 33, 1433, 10.1016/j.biotechadv.2014.10.008 Koller, 2007, Potential of various archae- and eubacterial strains as industrial polyhydroxyalkanoate producers from whey, Macromol. Biosci., 7, 218, 10.1002/mabi.200600211 Zhao, 2015, Biosynthesis, property comparison, and hemocompatibility of bacterial and haloarchaeal poly(3-hydroxybutyrate-co-3-hydroxyvalerate), Sci. Bull., 60, 1901, 10.1007/s11434-015-0923-8 Han, 2015, Biosynthesis, characterization, and hemostasis potential of tailor-made poly(3-hydroxybutyrate-co-3-hydroxyvalerate) produced by Haloferax mediterranei, Biomacromolecules, 16, 578, 10.1021/bm5016267 Zhao, 2013, Improving polyhydroxyalkanoate production by knocking out the genes involved in exopolysaccharide biosynthesis in Haloferax mediterranei, Appl. Microbiol. Biotechnol., 97, 3027, 10.1007/s00253-012-4415-3 Li, 2009, Synthesis, characterization and biocompatibility of biodegradable elastomeric poly(ether-ester urethane)s based on poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) and poly(ethylene glycol) via Melting polymerization, J. Biomater. Sci. Polym. Ed., 20, 1179, 10.1163/156856209X452944 Wang, 2004, Biodegradation studies of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate), Polym. Degrad. Stab., 85, 815, 10.1016/j.polymdegradstab.2004.02.010 Han, 2007, Molecular characterization of the phaECHm genes, required for biosynthesis of poly(3-hydroxybutyrate) in the extremely halophilic archaeon Haloarcula marismortui, Appl. Environ. Microbiol., 73, 6058, 10.1128/AEM.00953-07 Irani, 1997, Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value, J. Urol., 157, 1301 Stimac, 2014, Effect of histological inflammation on total and free serum prostate-specific antigen values in patients without clinically detectable prostate cancer, Korean J. Urol., 55, 527, 10.4111/kju.2014.55.8.527 Bluhm, 1986, Isodimorphism in bacterial poly(β-hydroxybutyrate-co-β-hydroxyvalerate), Macromolecules, 19, 2871, 10.1021/ma00165a035 Barham, 1984, Crystallization and morphology of a bacterial thermoplastic: poly-3-hydroxybutyrate, J. Mater. Sci., 19, 2781, 10.1007/BF01026954 Dinjaski, 2015, Smart polyhydroxyalkanoate nanobeads by protein based functionalization, Nanomedicine, 11, 885, 10.1016/j.nano.2015.01.018 López-Lara, 2016, Bacterial lipid diversity, Biochim. Biophys. Acta Qu, 2005, Enhanced vascular-related cellular affinity on surface modified copolyesters of 3-hydroxybutyrate and 3-hydroxyhexanoate (PHBHHx), Biomaterials, 26, 6991, 10.1016/j.biomaterials.2005.05.034 Wang, 2009, Surface engineering of PHBV by covalent collagen immobilization to improve cell compatibility, J. Biomed. Mater. Res. A, 88, 616, 10.1002/jbm.a.31858 Wang, 2003, Reduced mouse fibroblast cell growth by increased hydrophilicity of microbial polyhydroxyalkanoates via hyaluronan coating, Biomaterials, 24, 4621, 10.1016/S0142-9612(03)00356-9 Zhao, 2003, Polyhydroxyalkanoate (PHA) scaffolds with good mechanical properties and biocompatibility, Biomaterials, 24, 1041, 10.1016/S0142-9612(02)00426-X Olivares-Navarrete, 2015, Role of integrin subunits in mesenchymal stem cell differentiation and osteoblast maturation on graphitic carbon-coated microstructured surfaces, Biomaterials, 51, 69, 10.1016/j.biomaterials.2015.01.035 Hayden, 2014, Quantitative characterization of mineralized silk film remodeling during long-term osteoblast-osteoclast co-culture, Biomaterials, 35, 3794, 10.1016/j.biomaterials.2014.01.034 Jendrossek, 2002, Microbial degradation of polyhydroxyalkanoates, Annu. Rev. Microbiol., 56, 403, 10.1146/annurev.micro.56.012302.160838 Anderson, 2008, Foreign body reaction to biomaterials, Semin. Immunol., 20, 86, 10.1016/j.smim.2007.11.004 Thevenot, 2008, Surface chemistry influences implant biocompatibility, Curr. Top. Med. Chem., 8, 270, 10.2174/156802608783790901 Williams, 2005, Applications of polyhydroxyalkanoates (PHA) in medicine and pharmacy, Biopolymers, 4 Mader, 1996, Non-invasive in vivo characterization of release processes in biodegradable polymers by low-frequency electron paramagnetic resonance spectroscopy, Biomaterials, 17, 457, 10.1016/0142-9612(96)89664-5